Edition:
India

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.60USD
22 Jun 2018
Change (% chg)

$0.45 (+3.42%)
Prev Close
$13.15
Open
$13.25
Day's High
$13.70
Day's Low
$13.05
Volume
1,625,324
Avg. Vol
246,863
52-wk High
$19.80
52-wk Low
$4.45

Chart for

About

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program... (more)

Overall

Beta: 4.58
Market Cap(Mil.): $552.43
Shares Outstanding(Mil.): 70.37
Dividend: --
Yield (%): --

Financials

BRIEF-Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock

* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PRICING OF ITS PUBLIC OFFERING OF $150 MILLION OF COMMON STOCK

25 Jan 2018

BRIEF-Iovance Announces Preliminary Phase 2 Data For Til Treatment In Head And Neck And Cervical Cancers

* IOVANCE BIOTHERAPEUTICS ANNOUNCES PRELIMINARY PHASE 2 DATA FOR TIL TREATMENT IN HEAD AND NECK AND CERVICAL CANCERS

25 Jan 2018

BRIEF-Iovance Biotherapeutics‍ Intends To Offer And Sell $125 Mln Of Its Common Stock

* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

25 Jan 2018

BRIEF-Iovance Biotherapeutics Files For Mixed Shelf Of Up To $250 Mln

* IOVANCE BIOTHERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: (http://bit.ly/2zKJhqw) Further company coverage:

29 Dec 2017

Earnings vs. Estimates